Researchers have announced that the Atellica IM Testosterone II (TSTII) assay has received certification from the Centers for Disease Control and Prevention (CDC) for accurately measuring total testosterone levels. This certification confirms that the TSTII assay’s results are comparable to the gold-standard mass spectrometry method, making it a reliable and accessible option for both patients and laboratories. With this certification, the TSTII assay stands out as the only fully automated immunoassay to achieve this level of recognition, ensuring consistent and accurate testosterone testing.

This development is significant for anyone concerned about their hormonal health, as testosterone plays a crucial role in sexual development, reproductive function, and overall well-being. Accurate testosterone measurement is vital, particularly for men, women, and children, as abnormal levels can be linked to various health conditions. The TSTII assay’s certification means that healthcare providers can trust the results, leading to better diagnosis and treatment decisions, which is essential for maintaining muscle strength, energy levels, and overall health as you age.

The evidence supporting this assay comes from a recent evaluation published in a reputable medical journal. While the TSTII assay has been certified and used in clinical settings, it is important to note that this is a standardized testing method rather than a direct treatment or intervention. The certification enhances the reliability of testosterone measurements, but it does not replace the need for a comprehensive evaluation by healthcare professionals.

If you are concerned about your testosterone levels or overall hormonal health, consider discussing testing options with your healthcare provider. They can guide you on the best course of action based on your individual health needs.

Source: globenewswire.com